Giving an infusion of magnesium sulfate or Epsom
Salts just before delivery to pregnant
women who were at high risk for preterm birth, cut
the rate of cerebral palsy in the children born by
half, a new study found.
“This is one of the most promising breakthroughs in
the management of high-risk pregnancies in more than
30 years,” said Dr. John Thorp, a study co-author
and McAllister distinguished professor of obstetrics
and gynecology at the University of North Carolina at
“The active ingredient we used in this study, magnesium
sulfate, is better known as Epsom salt,” Thorp said.
“And virtually every delivery room in the United States
is already stocked with magnesium sulfate solutions
that are given to pregnant women during childbirth
for other reasons.
“So what we have learned from this study is that we
have a cheap, widely available treatment already in
hand that cuts in half the risk of babies being born
with an extremely disabling disorder. That is a
tremendously exciting development,” Thorp said.
In the study, 2,241 women who had been diagnosed at
high risk for giving birth prematurely, between 24
and 31 weeks into their pregnancies, were randomized
to receive an intravenous infusion of magnesium
sulfate solution or an identically appearing placebo.
The infusions were begun when delivery seemed imminent,
at a rate of 6 grams infused over 20-30 minutes
followed by a maintenance infusion of 2 grams per hour.
If delivery did not occur within 12 hours, the infusion
was stopped and resumed later when delivery once again
appeared at hand.
The researchers were looking to see if magnesium sulfate
reduced the rate of stillbirth or infant death, or
reduced the rate of moderate or severe cerebral palsy
at or beyond the age of 2 years. They found that the
risk of death did not differ significantly between the
magnesium sulfate and placebo groups. However, moderate
or severe cerebral palsy occurred about half as often
in the magnesium sulfate group than in the placebo group,
1.9 percent versus 3.5 percent.
Doctors who specialize in managing the pregnancies of
women at high risk for preterm birth could begin
using the magnesium sulfate treatment immediately,
if they choose to do so, Thorp said. Approval for the
treatment from the Food and Drug Administration is not
required. In addition, the U.S. and Australian studies
are the largest, most rigorously conducted and pertinent
trials to date and are not likely to be replicated,
According to Dr. Robert O. Young, a research scientist
at the pH Miracle Living Center, “magnesium sulfate or
Epsom salt can also be used for detoxing the liver
and bowel of dietary and metabolic acids.
Take 1 to 2 tablespoons of magnesium sulfate
in 1 liter of 9.5 alkaline water and drink the entire
solution within 5 to 10 minutes. This solution should
be ingested, first thing upon rising. The detoxing of
the bowel and liver generally takes place within 60
minutes after ingestion, so make sure you are close to